Xenon Pharmaceuticals (NASDAQ:XENE) reported its Q1 earnings results on Tuesday, May 10, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
Xenon Pharmaceuticals beat estimated earnings by 14.63%, reporting an EPS of $-0.35 versus an estimate of $-0.41.
Revenue was up $4.41 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.11 which was followed by a 3.09% increase in the share price the next day.
Here's a look at Xenon Pharmaceuticals's past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.37 | -0.38 | -0.48 | -0.40 |
| EPS Actual | -0.48 | -0.36 | -0.51 | -0.42 |
| Revenue Estimate | 4.97M | 10.22M | 2.33M | 5.15M |
| Revenue Actual | 3.74M | 8.12M | 2.22M | 4.36M |
To track all earnings releases for Xenon Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
